Title : Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs.

Pub. Date : 2019 Jan-Dec

PMID : 31409137






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs. Metformin epidermal growth factor receptor Homo sapiens
2 Conclusions: In conclusion, metformin may potentially enhance the therapeutic effect and increase survival in type 2 DM patients with lung cancer receiving EGFR-TKI therapy. Metformin epidermal growth factor receptor Homo sapiens